Pharmaceutical company to pay $95M to settle allegations of improper drug promotion

WASHINGTON — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday. The Justice Department said …

Share